NAD+ therapy has become much more popular, but that alone does not answer the most important question: Does NAD therapy actually work? Is there solid clinical evidence for NAD, or is it just another wellness trend that makes big promises but does not deliver? Here is an honest look at what the science shows and what patients can expect.

The Mechanistic Evidence Is Strong

Research at the cellular and molecular level shows that NAD+ is important for energy metabolism, DNA repair, gene regulation, and how cells respond to stress. Many studies over the years have confirmed that NAD+ levels drop as we age, and this drop is linked to age-related decline. These findings are supported by a lot of peer-reviewed research.

In animal studies, raising NAD+ levels has led to better mitochondrial function, improved DNA repair, healthier metabolism, more exercise capacity, and even longer lifespans in some species. These results have been published in leading journals like Cell, Nature, and Science.

Human Clinical Evidence: Growing but Still Developing

This is where an honest assessment requires nuance. Human clinical trials specifically on NAD+ therapy are increasing in number but remain limited compared with animal data. A 2018 trial published in Nature Communications demonstrated that NR supplementation safely raised NAD+ levels in healthy adults, confirming that the NAD+ boosting concept works in humans. Additional studies have shown improvements in markers of cardiovascular health, insulin sensitivity, and exercise performance with NAD+ precursor supplementation.

However, large-scale, long-duration randomized controlled trials examining clinical outcomes of direct NAD+ injection or IV therapy in healthy aging adults are not yet available. Much of the clinical support for these specific delivery methods comes from smaller studies, clinical practice observations, and extrapolation from the precursor data. This doesn't mean the therapy doesn't work—it means the gold-standard evidence is still being built.

What Patients Report

The effectiveness of NAD therapy is also supported by consistent patient-reported outcomes across clinical practices. The most commonly reported benefits include improved energy and reduced fatigue, better mental clarity and focus, enhanced recovery from physical activity, improved sleep quality, and a general sense of improved vitality. These reports are consistent across different clinics and patient populations, which lends credibility even in the absence of massive controlled trials.

Where the Evidence Has Gaps

To maintain credibility, it's important to acknowledge what the evidence does not yet support. NAD+ therapy has not been proven to extend human lifespan. It has not been demonstrated to cure or treat any specific disease in controlled human trials. The optimal dosing, frequency, and delivery method for different populations has not been definitively established. And long-term safety data for direct NAD+ injection therapy in humans are limited.

These gaps don't invalidate the therapy—they simply mean the field is still maturing. This is a common stage for many therapeutic approaches that eventually become standard practice.

A Balanced Verdict

Does NAD+ therapy work? The honest answer is that the mechanistic evidence strongly supports its potential, animal data are compelling, early human data are encouraging, and patient-reported outcomes are consistently positive. The strongest statement the evidence currently supports is that NAD+ therapy can restore declining NAD+ levels and that doing so appears to produce meaningful improvements in energy, cognition, and recovery for many patients. Whether it delivers on the more ambitious longevity claims remains to be proven through larger, longer-term human studies.

At HRT Wellness, we present NAD+ therapy honestly—including what the evidence supports and where it has room to grow. Schedule a consultation to discuss whether NAD+ therapy might be a good fit for your health goals.

References

  1. Yoshino J, Baur JA, Imai S. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27(3):513–528.
  2. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+. Nature Communications. 2018;9(1):1286.
  3. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules. Cell. 2018;154(6):1350–1364.